A comparison study of amitriptyline and nortriptyline with plasma levels

Area of Science:

• Psychiatry
• Pharmacology
• Clinical Medicine

Background:

• Depression is a prevalent mood disorder requiring effective pharmacotherapy.
• Tricyclic antidepressants (TCAs) like amitriptyline and nortriptyline are commonly prescribed.
• Optimizing TCA plasma levels is crucial for therapeutic efficacy.

Purpose of the Study:

• To compare the efficacy of amitriptyline hydrochloride and nortriptyline hydrochloride in treating depression.
• To investigate the relationship between plasma TCA levels and treatment response.
• To determine if plasma TCA levels within the therapeutic range improve depression outcomes.

Main Methods:

• A randomized clinical trial involving 41 depressed outpatients.
• Patients were assigned to receive either amitriptyline hydrochloride or nortriptyline hydrochloride for six weeks.
• Plasma TCA levels were measured and correlated with depression scores (Hamilton and Zung).

Main Results:

• Both amitriptyline and nortriptyline demonstrated equal effectiveness in treating depression.
• A negative correlation between Hamilton Score and TCA levels was observed in amitriptyline-treated patients.
• Patients with plasma TCA levels within the therapeutic range showed significantly better response across multiple outcome measures.

Conclusions:

• Amitriptyline and nortriptyline are equally effective treatments for depression.
• Maintaining plasma TCA levels within the established therapeutic range is associated with improved treatment outcomes.
• Plasma level monitoring may aid in optimizing TCA therapy for depressed patients.